Scottsdale, Arizona 11/25/2009 2:36:43 AM
News / Business

Cardio Vascular Medical Device Corp. (CVSL.OB) Applying for Patents in Europe, Canada, and Far East

QualityStocks would like to highlight Cardio Vascular Medical Device Corp. (OTCBB: CVSL). Cardio Vascular Medical Device Corp. holds the US patent for the innovative Steerable Guidewire applicable for all PCTA (angioplasty) procedures. The CVSL guidewire overcomes the limitations of the existing generation of guidewires.

 

In the company’s news yesterday,

 

Cardio Vascular Medical Device Corp. announced that it will apply for additional patents for its proprietary steerable guidewire product for use in angioplasty procedures. The company already holds a U.S. patent for its innovative guidewire, but wants to obtain patents in Europe, Canada, and the Far East in order to penetrate a worldwide commercial marketplace for the life-saving angioplasty procedure. The steerable guidewire is applicable for all angioplasty procedures, and the potential market for related equipment exceeds $500 million.

 

Angioplasty is now a common procedure, performed to widen narrowed or obstructed blood vessels. It is often performed in place of, or before, more invasive and potentially life-threatening bypass surgery. Heart disease kills over 7 million people worldwide each year and is the leading cause of death for both men and women in the U.S. Angioplasty performed prior to an artery being fully blocked can prevent the onset of heart attacks.

 

The guidewire, principal product of Cardio Vascular, offers a number of advantages over the competition.

 

• Improved performance

• Faster use, enabling the neurosurgeon to reach the desired location

• Controlled bending angle

• Easy to use handle

• Quick detachment from the operating handle

• Available in all ongoing sizes

• Cost efficiency for patient and a health care providers

 

Eli Gonen, CEO of Cardio Vascular Medical Device Corp., commented on the importance of the technology in the world market. “Filing these additional patent applications is the first stage in aiding cardiologists in the process of saving lives across the globe. The ability to steer our guidewire during angioplasty procedures using our patented flexi-tip enables more difficult procedures to be completed with greater ease, and speeds overall procedure time. Due to these significant advantages, Cardio Vascular Medical Device’s guidewire has the opportunity to become the guidewire of choice for surgeons throughout the world.”

 

About QualityStocks

 

QualityStocks, based in Scottsdale, Arizona is a free service that collects data from hundreds Small-Cap and Micro-Cap online Investment Newsletters into one Free Daily Newsletter Report. QualityStocks is dedicated to assisting emerging public companies with their advertising efforts and now has over 750,000+ subscribers that receive The Daily Stock Newsletters.

 

To sign up for “The QualityStocks Daily Newsletter” please visit www.QualityStocks.net

 

Please see disclaimer on QualityStocks website: http://Disclaimer.QualityStocks.net 

 

Forward-Looking Statement:

This release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Risks and uncertainties applicable to the company and its business could cause the company's actual results to differ materially from those indicated in any forward-looking statements.